Firebrick Pharma LimitedASX: FRE

Registration Agreement and Approval of Nasodine in Indonesia

· Issued by Firebrick Pharma Limited

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Firebrick Pharma Limited has announced the approval of Nasodine Nasal Spray for importation and distribution in Indonesia, marking its first regulatory approval for the product. The approval allows Firebrick to access the Indonesian market, which is significant due to its large population and status as the largest market in Southeast Asia. The company plans to manufacture the product with local language packaging and secure a marketing partner before commencing sales.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Firebrick Pharma Limited on 6ix

Story so far

Earlier from Firebrick Pharma

Later from Firebrick Pharma

All Firebrick Pharma news releases